EyeOnBI.org is part of an effort to return Beth Israel Deaconess to its founding principles and ensure that the administration is putting the interests of patients, workers and community members first. Read more

« Another Major Quality Breakdown at Beth Israel Deaconess Medical Center | Main | Joint Commission says BI needs improvement »

BI suspends enrollment in cancer trials following data lapse

BIDMC suspended enrollment in cancer trials after an audit showed data documentation and reporting problems. Problems began to surface last summer, when federal regulators (the FDA) found that in one trial “[s]ome of the serious adverse events” experienced by patients were submitted to oversight authorities “later than required.”

 October 21, 2010 Cancer trials suspended for new patients

References (3)

References allow you to track sources for this article, as well as articles that were written in response to this article.
  • Response
    Response: Hollister
    EyeOnBI - Patient Problems - BI suspends enrollment in cancer trials following data lapse,Ovaj članak je napisan tačno Međutim, ako želite vidjeti srodnih proizvoda možete pogledati na ovdje:Hollister,
  • Response
    Cancer is one of the major diseases that should not be negligible by any doctors because it is the matter of life and death. Any symptoms seen in any patient should get the medical services as soon as possible.
  • Response
    Response: Bulk buy lanyards

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>